株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

ポイントオブケア診断:企業・製品・将来市場の予測

Point of Care Diagnostics Market: Products, Players and Outlook

発行 Espicom Business Intelligence 商品コード 231722
出版日 ページ情報 英文 4 volumes + Bundle of 5 separate reports
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
ポイントオブケア診断:企業・製品・将来市場の予測 Point of Care Diagnostics Market: Products, Players and Outlook
出版日: 2013年05月16日 ページ情報: 英文 4 volumes + Bundle of 5 separate reports
概要

2011年の体外診断市場額は2010年から約4%成長し、約430億米ドルとなりました。ポイントオブケア(POC)部門は市場全体の35%を構成し、2011年の市場額は151億米ドルとなりました。POC部門は全体的なIVD市場よりも急速に成長しています・

当レポートでは、ポイントオブケア(POC)診断市場について調査し、主な診断分野における売上の5ヵ年予測、市場展望および変化・革新を促進する企業の分析を提供しており、概略下記の構成でお届けいたします。

目次

心臓病:POC診断−製品・企業・展望

  • 市場概要
  • POC心血管製品:技術
  • 血小板機能・抗血小板薬の評価
  • POC心臓マーカー検査
  • POCコレステロール検査
  • メーカー
  • 付録

病院:POC診断−製品・企業・展望

  • エグゼクティブサマリー
  • 病院用POC検査製品・技術
  • POC血液学・止血製品
  • POC心臓マーカー検査
  • POC尿検査
  • 病院用POC検査メーカー
  • 付録

感染症:POC診断−製品・企業・展望

  • エグゼクティブサマリー
  • 製品・技術
  • その他のプライマリーケアPOC検査
  • 肝炎検査
  • 複合POC検査
  • POC結核検査
  • POC性感染症検査
  • POC熱帯病検査
  • 新興技術
  • POCメーカー
  • 主要企業のプロファイル
  • 付録

医師用:POC診断−製品・企業・展望

  • 市場概要
  • POCコレステロール検査
  • POC凝固検査
  • POC臨床化学・血液学製品
  • POC C反応性タンパク診断
  • POC診療所用感染症検査
  • POC腫瘍マーカー検査
  • POC尿検査
  • その他の製品
  • 新興技術
  • メーカー
  • 付録

ポイントオブケア(POC)診断:市場概要

  • エグゼクティブサマリー
  • 背景
    • POCの役割
  • 現在の市場力学
    • POC診断製品の顧客
    • 地域別の展望
    • 規制・医療費償還環境
    • 臨床試験室改善修正条項放棄(CLIA Waiver)
  • 競合情勢
    • 業界再編
  • 成長促進因子・阻害因子・将来の機会
    • 臨床的有用性・正確性
    • ディスラプティブ技術としてのPOC診断
    • 接続性
    • POC診断と経済
    • 将来の技術:次世代POC診断製品
      • コンパニオン診断
      • PCR・DNAベースの技術
    • ラボオンチップ装置・マイクロ流体工学
  • 市場展望

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 978 1 909584 26 6

Abstract

A complete and practical analysis packed with facts, figures, forecasts and product/competitive assessments!

The point-of-care (POC) diagnostics market encompasses a wide range of products used outside the central laboratory, by either healthcare professionals, patient self-testers as supervised by a healthcare practitioner or by consumers. This includes products that test blood glucose levels, blood coagulation, fertility and pregnancy, infectious and cardiovascular disease and cancer, as well as hospital testing in areas such as critical care, surgical and emergency departments.

Critical analysis and 5-year forecasts of key point-of-care diagnostic technologies, their prospects and the companies driving change and innovation.

The In Vitro diagnostics market was worth approximately US$43 billion in 2011 and grew approximately 4% compared with 2010. The Point-of-Care (POC) sector represents 35% of the overall market and was valued at US$15.1 billion in 2011.

The products covered in this report include those used by healthcare professionals and self-testers, which accounted for 33% of the POC sector, and consumer POC products which represented 7%. The remaining 60% of sales comes from blood glucose monitoring products.

The POC sector is growing faster than the overall IVD market. During 2011, growth in the POC sector, excluding consumer and glucose testing products, is estimated to have been 7%. Growth was driven by the increasing adoption of all types of POC technologies by both professional and self-testing users, as well as the launch of new products and rising demand in emerging markets.

POC Diagnostics is a sector on the move. Key reasons why it is interesting:

  • POC diagnostics play a key role in the diagnosis and monitoring of acute and chronic illnesses, the detection of some types of cancer and infectious diseases, and for general blood and urine testing. It can also play a role in preventative medicine, which is intended to help curb the increasing incidence of chronic conditions such as diabetes and cardiovascular disease through early detection and the identification of patients with risk factors.
  • POC testing offers clear benefits over laboratory testing. As it is conducted near the patient, results are available more quickly, enabling healthcare providers to act swiftly to emergencies such as heart attack and provide a diagnosis while the patient is still in the healthcare facility, speeding treatment and reducing visits to the doctor. For patients, self-testing helps users control effectively their condition which lowers the time and cost of treating complications, and the need for them to regularly see their doctor.
  • The POC diagnostics market is dominated by well-established and accepted product areas such as infectious disease and pregnancy testing. However, there is major growth potential for the adoption of POC technologies in settings such as hospital emergency, critical care and out-patient departments and areas without access to central labs.

This report collection delivers a complete and insightful analysis

The four volumes of this report collection, originally published Autumn 2012/Spring 2013, make a fascinating and detailed appraisal of this fast-growing sector of the diagnostics industry worldwide. Whatever your interest, the report will provide a one-stop assessment of opportunities and challenges going forward.

A special collection of insightful management reports available as a discounted set:

  • Vol 1: Cardiology Diagnostics
  • Vol 2: Hospital-based Diagnostics
  • Vol 3: Physician-based Diagnostics
  • Vol 4: Infectious Diseases Diagnostics
  • + Point of Care Market Overview

Use this extensive 4-volume report to...

  • Understand the trends which are shaping the sector's operation
  • Identify which sectors offer the greatest growth potential over the next 5 years
  • Highlight the emerging companies in the industry with novel technology
  • Evaluate the competitive landscape and identify the companies to watch
  • Know who's striking strategic and tactical partnerships
  • Monitor M&A activity and the changing competitive landscape

About the Author

This report has been researched and written by independent medical market analyst Joanne Maddox. For over 13 years she has played a pivotal role in tracking trends in medical device and equipment markets and companies. A former editor of Medical Device Companies Analysis she has also written The Global Advanced Wound Care Market to 2017; Advances in Molecular Imaging 2013; and, Telemonitoring: Challenges and Opportunities.

About the Publisher

For over 30 years Espicom Business Intelligence, a Business Monitor company, has been a leading provider of key medical device and technology data. Its experienced and knowledgeable authors are uniquely placed to produce this high-quality and thoroughly researched management report. Espicom is part of Business Monitor International.

Table of Contents

Cardiology

Point-of-Care Diagnostics - Products, Players and Outlook to 2017

MARKET OVERVIEW

  • EXECUTIVE SUMMARY
  • INTRODUCTION
    • POC Cardiovascular POC
    • The Role Of POC Testing in Cardiovascular Care
    • Customers of POC Cardiovascular Diagnostic Products
    • POC Cardiovascular Technologies by Customer Segment
    • Regulatory and Reimbursement Environment
    • CLIA Waiver
  • CURRENT MARKET DYNAMICS
    • Fig.1: POC Diagnostics in Relation to the IVD Market, 2011
    • Fig.2: Percentage of POC Diagnostics Market by Product, 2011
    • Regional Perspective
    • Fig.3: Professional POC Diagnostics Market by Region, 2011
    • POC Cardiovascular Testing Market
    • POC Cardiovascular Diagnostics Market by Product Type, 2007-2011 (US$ million)
    • Fig.4: Cardiac POC Testing Market by Product, 2011
  • GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
    • The Burden of Cardiovascular Disease
    • POC Diagnostics and the Economy
    • POC Diagnostics as a Disruptive Technology
    • Clinical Utility and Accuracy
    • Connectivity
    • Emerging Technologies
    • Companion Diagnostics
    • Lab-on-a-Chip Devices and Microfluidics
    • Summary: Market Drivers, Restraints and Opportunities
  • COMPETITIVE LANDSCAPE
    • Market Leaders for Cardiovascular POC Testing Products
    • Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million)
    • Merger and Acquisition Activity
    • Key POC Diagnostics Mergers and Acquisitions, 2008-2011
  • FUTURE MARKET PROSPECTS
    • POC Cardiovascular Testing Market by Product Type, 2011-2017E (US$ million)
    • POC Cardiovascular Testing Market by Product Growth, 2008-2017E (%)

POC CARDIOVASCULAR PRODUCTS AND TECHNOLOGIES

  • POC COAGULATION TESTING
  • POC Coagulation Testing Market Dynamics
    • Fig.5: Global POC Coagulation Market, 2007-2017E (US$ million)
    • The Impact of New-Generation Anticoagulants
  • Self-Monitoring Products
    • CoaguSense's CoaguSense PT/INR Monitoring System
    • Alere's INRatio2 System
    • International Technidyne Corporation's ProTime System
    • ProTime Microcoagulation System
    • Roche's CoaguChek XS
  • Professional Use Products
    • Abbott's i-STAT System
    • i-STAT Cartridges
    • Alere's Axis-Shield Products
    • Helena Laboratories' Cascade POC System
    • Helena Laboratories' Actalyke & MAX-ACT
  • Medtronic's ACT Plus Automated Coagulation Timer System
  • Instrumentation Laboratory's GEM PCL Plus
  • ITC's Hemochron Whole Blood Coagulation System
    • Hemochron Signature Elite and Hemochron Signature Plus Microcoagulation System
    • Hemochron Response
  • Radiometer's AQT90 FLEX Immunoassay Analyser
    • Roche's CoaguChek Systems
    • CoaguChek XS Pro
    • CoaguChek XS Plus
    • CoaguChek XS
    • CoaguChek Link
  • Products in Development
    • Bio-AMD's COAG
    • Siemens/Universal Biosensors' POC Coagulation Tests
  • Surgical Coagulation and Haemostasis Management
    • Akers Biosciences' PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays
    • Haemonetics' TEG Thrombelastograph Hemostasis Analyzer
    • Medtronic's HMS PLUS Haemostasis Management System
    • Pentapharm's ROTEM delta
    • Sienco's Sonoclot Coagulation & Platelet Function Analyzers

PLATELET FUNCTION AND ANTIPLATELET DRUG ASSESSMENT

  • Clinical Guidelines
  • Accumetrics' VerifyNow System
    • Clinical Studies
  • Helena Laboratories' Plateletworks System
  • Clopidogrel Effectiveness Assessment
    • Spartan Bioscience's Spartan RX CYP2C19 POC DNA Testing System
    • Clinical Studies

POC CARDIAC MARKER TESTING

  • PROTECT Study
    • VISION Study
  • POC Testing
    • Gaining Clinical Evidence
    • Market Dynamics
    • Fig.6: Global POC Cardiac Marker Testing Market, 2007-2017E (US$ million)
    • POC Testing Products
    • Currently-Available Cardiac Marker POC Tests
    • Abbott's i-STAT System
    • Alfa Wassermann's ACE Clinical Chemistry Systems
    • Alere's Heart Check System
    • Alere's Triage and Clearview Products
    • Audit Diagnostics' DryLab
    • bioMérieux VIDAS and bioNexia Tests
    • Nexus Dx/Samsung's LABGEO POC Cardiovascular Analysers
    • Mitsubishi Chemical's Pathfast Immunoassay Analyzer
    • Ortho-Clinical Diagnostics' VITROS DT60 II Chemistry System
    • Radiometer's AQT90 FLEX Immunoassay Analyser
    • Randox Laboratories' Evidence Multistat
    • ReLIA Diagnostic Systems' ReLIA System
    • Response Biomedical's RAMP Platform
    • Roche Cardiac Testing Products
    • Siemens' Stratus CS Analyzer
    • Tosoh Bioscience's AIA-360 Immunoassay Analyser
    • Products in Development

POC CHOLESTEROL TESTING

  • Cholesterol Testing and Preventative Medicine
  • POC Cholesterol Testing Market Dynamics
    • Fig.7: Global POC Cholesterol Testing Market, 2007-2017E (US$ million)
  • Professional Use Products
    • Abaxis' Piccolo xpress
    • Alere's Cholestech LDX System
    • Alfa Wassermann's ACE Clinical Chemistry Systems
    • Arkray's SpotChem Dry Chemistry Analysers
    • Audit Diagnostics' Liqui-Stat System
    • Horiba ABX' Pentra Clinical Chemistry Analysers
    • Jant Pharmacal's LipidPlus Lipid Profile and Glucose Test System
    • Polymer Technology Systems' CardioChek PA
    • Miraculins' PreVu Point of Care Skin Sterol Test
    • Distribution Agreements
    • Samsung's LABGEO PT10 Clinical Chemistry Analyzer
    • Products in Development
    • Roche and Panasonic Healthcare
  • Home Testing
    • Alere's First Check Cholesterol Test
    • Akers Biosciences' Tri-Cholesterol Check
    • Chematics Chemcard Cholesterol Test
    • Infopia's Lipid Pro
    • Roche's Accutrend Plus
    • Syntron Bioresearch's Venture Total Cholesterol Test
  • EMERGING TECHNOLOGIES
    • Ativa Medical's POC Analyser
    • Atonomics' Atolyzer
    • Bio-AMD's MPR
    • Biosensia's RapiPlex
    • Fiomi Diagnostics (Trinity Biotech) Forecast Technology
    • MagnaBioSciences' MICT On-Site System
    • Molecular Vision
    • MycroLab
    • OPKO Health's OPKO Diagnostics Platform
    • Philips' Minicare
    • Radisens Diagnostics' POC Platform
    • T2 Biosystems' T2Dx System
    • T2Hemostasis Assay

MANUFACTURERS

  • COMPANY DIRECTORY
  • SELECTED COMPANY PROFILES
    • Abbott
    • Recent Key Events
    • i-STAT Point-of-Care Products
    • i-STAT Cartridges
    • Financial Performance
    • Abbott Point of Care Sales, 2010-2011 (US$ million)
    • Fig.8: Percentage of Abbott Point of Care Revenue by Region, 2011
  • Accumetrics
    • Recent Key Events
    • Fig.9: Accumetrics Revenue, 2005-2011 (US$ thousand)
    • VerifyNow System
    • Distribution Agreements
  • Akers Biosciences
    • Recent Key Events
  • Current Products
    • PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays
    • Tri-Cholesterol Check
  • Current Alliances and Distribution Agreements
    • Al Tadawi Medical Equip/ PharmaNova Medical Equipment
    • Fisher HealthCare
  • Financial Performance
    • Akers Biosciences Operating Results, 2007-2011 (US$ thousands)
    • Fig.10: Percentage of Akers' Revenue by Product Type, 2011

Alere

  • Recent Key Events
  • POC Cardiology Diagnostic Products
    • Triage Cardiac Marker Tests
    • Alere Heart Check System
    • Cholestech LDX
    • INRatio2 System
    • Axis-Shield Products
    • RALS-Plus POC IT Solution
  • Alere Consumer Products
  • POC Mergers & Acquisitions
    • Axis-Shield
    • Medical Automation Systems'
    • Standard Diagnostics
    • Mologic, Jinsung Meditech, Biolinker and Long Chain International Corp
    • Zycare, Medim and Biosyn
    • ACON Laboratories' Rapid Diagnostics Assets
    • Matria Healthcare
    • BBI Holdings
    • Other Acquisitions
  • Current Alliances
    • Spartan Bioscience
    • Epocal
  • Financial Performance
    • Alere - Operating Results, 2007-2011 (US$ million)
    • Fig.11: Percentage of Alere's Revenue by Segment, 2011
    • Fig.12: Percentage of Alere's Revenue by Region, 2011
    • Alere Professional Diagnostics Operating Results, 2007-2011 (US$ million)
    • Alere Professional Diagnostics Net Sales & Services Revenue, 2007-2011 (US$ million)
    • Fig.13: Alere Professional Diagnostics Net Sales & Services Revenue by Product, 2011
    • Alere Consumer Diagnostics Operating Results, 2007-2011 (US$ million)
    • Latest Results
    • Axis Shield - Financial Performance
    • Fig.14: Axis-Shield Revenue by Business Unit, 2010
    • Fig.15: Axis-Shield Revenue by Region, 2010
    • Axis-Shield - POC Segment Operating Results, 2006-2010 (£ million)
    • Axis-Shield - POC Sales by Product Line, 2006-2010 (£ million)
    • Fig.16: Axis-Shield POC Sales by Product, 2010
    • Fig.17: Axis-Shield Afinion Sales by Region, 2010
  • bioMérieux
    • bioNexia POC Tests
    • VIDAS Tests
    • VIDAS NT-proBNP
    • VIDAS Troponin I Ultra
    • VIDAS D-Dimer Exclusion
    • VIDAS B-R-A-H-M-S PCT. Test
  • Current Alliances
    • Uppsala Clinical Research Center
    • Philips
    • Sysmex
    • Abaxis
    • ReLIA Diagnostic Systems
    • Roche Diagnostics
    • Brahms
    • Financial Performance
    • bioMérieux - Operating Results, 2007-2011 (EUR million)
    • Fig.18: Percentage of bioMérieux' Revenue by Product Type, 2011
    • Fig.19: Percentage of bioMérieux' Revenue by Region, 2011
  • International Technidyne Corporation
    • Products
    • ProTime Microcoagulation System
    • Hemochron Whole Blood Coagulation System
    • IRMA TRUpoint Blood Analysis System
    • AVOXimeter Whole Blood CO Oximeter and Oximeter
    • Current Alliances
    • Alere.
    • Financial Performance
    • International Technidyne Operating Results, 2004-2009 (US$ million)
    • Fig.20: International Technidyne Revenue, 2000-2010 (US$ million)
  • Radiometer (Danaher)
    • Recent Key Events
    • AQT90 FLEX Immunoassay Analyser
    • AQURE POC Management System
    • Financial Performance
    • Fig.21: Radiometer - Revenue by Region, 2010
  • Response Biomedical
    • Recent Key Events
    • RAMP System
    • Cardiac Marker Tests
    • Current Alliances
    • Fisher Scientific
    • Cremascoli
    • O&D Biotech
    • Guangzhou Wondfo Biotech
    • Shionogi
    • Financial Performance
    • Response Biomedical - Operating Results, 2007-2011 (C$ thousand)
    • Response Biomedical - Product Sales by Category, 2009-2011 (C$ thousand)
    • Fig.22: Response Biomedical - Product Sales by Category, 2011
    • Response Biomedical - Revenue by Region, 2009-2011 (C$ thousand)
    • Fig.23: Response Biomedical - Revenue by Region, 2011
    • Latest Results
  • Roche Diagnostics
    • Recent Key Events
    • CoaguChek Systems
    • CoaguChek XS Pro
    • CoaguChek XS Plus
    • CoaguChek XS
    • CoaguChek Link
    • Cardiac Testing Products
  • cobas h 232 Portable Cardiac Testing Device
    • Cardiac Reader
    • TROP T Sensitive Rapid Assay
    • cobas POC IT Solution
    • Current Alliances and Contracts
    • Panasonic Healthcare
    • Eidia (Eisai)
    • Voluntis
    • Radiometer
    • bioMérieux
    • Alere
    • Dade Behring (Siemens)
  • Financial Performance
    • Roche Diagnostics Operating Results, 2010-2011 (SFr million)
    • Fig.24: Roche Diagnostics - Revenue by Product Line, 2011
    • Fig.25: Roche Professional Diagnostics - Revenue by Region, 2011
    • Latest Results
  • Siemens Healthcare
    • Recent Key Events
    • Stratus CS Acute Care Diagnostic System
    • Current Alliances and Supply Contracts
    • Universal Biosensors
    • Premier
    • Roche
    • Financial Performance
    • Latest Results

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY

Hospital

Point-of-Care Diagnostics - Products, Players and Outlook to 2017

EXECUTIVE SUMMARY

  • INTRODUCTION
    • POC Testing in a Hospital Setting
  • CURRENT MARKET DYNAMICS
    • Fig.1: POC Diagnostics in Relation to the IVD Market, 2011
    • Fig.2: Percentage of POC Diagnostics Market by Product, 2011
    • Regional Perspective
    • Fig.3: Professional POC Diagnostics Market by Region, 2011
    • Regulatory and Reimbursement Environment
    • CLIA Waiver
    • Hospital POC Testing Market
    • Hospital POC Testing Market by Product Type, 2007-2011 (US$ million)
    • Fig.4: Hospital POC Testing Market by Product Type, 2011
  • COMPETITIVE LANDSCAPE
    • Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million)
    • Market Leaders by Hospital POC Testing Product Type
    • Merger and Acquisition Activity
    • Key Hospital POC Diagnostics Mergers and Acquisitions, 2008-2012
  • GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
    • Clinical Utility and Accuracy
    • Connectivity
    • POC Diagnostics as a Disruptive Technology
    • POC Diagnostics and the Economy
    • Future Technology: Next-Generation POC Diagnostic Products
    • Lab-on-a-Chip Devices and Microfluidics
    • Detecting Hospital-Acquired Infections
    • Summary: Market Drivers, Restraints and Opportunities
  • FUTURE MARKET PROSPECTS
    • Hospital POC Testing Market by Product Type, 2011-2017E (US$ million)
    • Hospital POC Testing Market by Product Growth, 2008-2017E (%)
    • Fig.5: Predicted Hospital POC Testing Market by Product, 2017

HOSPITAL POC TESTING PRODUCTS AND TECHNOLOGIES

  • MULTI-FUNCTIONAL CLINICAL CHEMISTRY ANALYSERS
    • Abaxis' Piccolo xpress
    • Abbott's i-STAT System
    • Alfa Wassermann's ACE Clinical Chemistry Systems
    • Arkray's SpotChem Systems
    • SpotChem Test Strips
    • Audit Diagnostics' Liqui-Stat and DryLab Systems
    • DiaSys Diagnostic Systems' InnovaStar
    • Horiba's ABX Pentra Clinical Chemistry Analysers
    • Ortho-Clinical Diagnostics' VITROS DT60 II Chemistry System
    • Radiometer's AQT90 FLEX Immunoassay Analyser
    • Randox Laboratories' Evidence Multistat
    • Samsung's LABGEO Clinical Chemistry Analysers
    • Tosoh Bioscience's AIA Immunoassay Analysers
  • POC BLOOD GAS/ELECTROLYTE ANALYSERS
    • Fig.6: POC Clinical Chemistry Market, 2007-2017E (US$ million)
  • Arkray's SpotChem EL Electrolyte Analyser
  • Epocal's epoc Blood Analysis System
  • Instrumentation Laboratory's GEM Premier Products
    • tBili Assay
  • GEMweb Plus
  • ITC's IRMA TRUpoint Blood Analysis System
  • ITC's AVOXimeter Products
  • Nova Biomedical's Critical Care Analysers
    • pHOx Ultra Blood Gas Analyser
    • Stat Profile pHOx
    • Stat Profile Critical Care Xpress
    • Nova Electrolyte/Chemistry Analysers
    • Hand-Held Analysers
  • OPTI Medical Systems' Products
    • Radiometer's Blood Gas Analysers
    • 1st automatic
    • ABL90 FLEX
    • ABL800 FLEX
    • Avoid Errors App
  • Roche's cobas Blood Gas Analysers
  • Siemens' Blood Gas Analyser Range
    • RAPIDPoint Analysers
    • RAPIDLab Analysers
    • RAPIDChem 744/754 Electrolyte and Lithium Testing
    • RAPIDComm Data Management and Connectivity Solution
  • Via Medical's Products

POC HAEMATOLOGY AND HAEMOSTASIS PRODUCTS

  • Fig.7: Global POC Haematotolgy Market, 2007-2017E (US$ million)
  • Haematology Analysers
    • Beckman Coulter's COULTER AC-T Series
    • Horiba's Haematology Analysers
    • Samsung's LABGEO HC10
    • Sysmex' pocH-100i Haematology Analyser
  • POC Haemoglobin Systems
    • POC Analyser Accuracy
    • Available Products
  • Arkray's PocketChem BA Blood Ammonia Meters
  • Surgical Coagulation and Haemostasis Management
    • Akers Biosciences' PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays
    • Haemonetics' TEG Thrombelastograph Hemostasis Analyzer
    • Medtronic's HMS PLUS Haemostasis Management System
    • Pentapharm's ROTEM delta
    • Sienco's Sonoclot Coagulation & Platelet Function Analyzers
  • Platelet Function Assessment
    • Clinical Guidelines
    • Accumetrics' VerifyNow System
    • Helena Laboratories' Plateletworks System

POC CARDIAC MARKER TESTING

  • PROTECT Study
    • VISION Study
  • POC Testing
    • Gaining Clinical Evidence
    • Market Dynamics
    • Fig.6: Global POC Cardiac Marker Testing Market, 2007-2017E (US$ million)
  • POC Testing Products
    • Currently-Available Cardiac Marker POC Tests

POC URINALYSIS

  • Fig.9: Global POC Urinalysis Market, 2007-2017E (US$ million)
    • Key Urine Analysis Test Strips
    • Product Highlights
    • 77 Elektronika's DocUReader 2 and DocuReader 2 Pro
    • ACON Laboratories' Mission Products
    • Arkray's Products
    • Roche's Products
    • Siemens' Products
  • OTHER POC PRODUCTS
    • Labour and Delivery Testing
    • Alere's Triage PLGF Assay
    • Amnisure International's AmniSure ROM Test
    • Medix Biochemica's Actim PROM and Actim Partus
    • Liver Function Testing
    • Exalenz Bioscience's BreathID System
    • Infopia's Pioneer POCT Liver Test Sensor
    • Alere's Triage NGAL Test
    • bioMérieux' VIDAS B-R-A-H-M-S PCT. Test
    • Magellan Biosciences' LeadCare II System
    • Medix Biochemica's Actim Pancreatitis
    • Products in Development
    • Akers Biosciences' BreathPulmo Health Check and Breath Asthma Check
  • EMERGING TECHNOLOGIES
    • Applied Nanodetectors' Sensor Array Platform
    • Atonomics' Atolyzer
    • Ativa Medical's POC System
    • Bio-AMD's MPR
    • Biosensia's RapiPlex
    • Fiomi Diagnostics (Trinity Biotech) Forecast Technology
    • MagnaBioSciences' MICT On-Site System
    • Micronics' ABORhCard and ABO-XM Card
    • Molecular Vision
    • MycroLab
    • OPKO Health's OPKO Diagnostics Platform
    • pes diagnosesysteme' respons IQ
    • Philips' Minicare
    • Radisens Diagnostics' POC Platform
    • T2 Biosystems' T2Dx System
    • T2Hemostasis Assay
    • Tyrian Diagnostics' DiagnostIQ
    • Hospital-Acquired Infection Testing
    • Cepheid's GeneXpert
    • Atlas Genetics' POC System
    • BioFire Diagnostics' FilmArray System
    • Immunexpress' SeptiCyte Technology
    • Rheonix' EncompassMDx Platform

HOSPITAL POC TESTING MANUFACTURERS

  • COMPANY DIRECTORY
  • SELECTED COMPANY PROFILES
    • Abaxis
      • Piccolo xpress
      • Financial Performance
      • Abaxis Operating Results, 2007-2012 (US$ million)
    • Abbott
      • Recent Key Events
      • i-STAT Point of Care Products
      • Alliance with Abaxis
      • Financial Performance
      • Abbott Point of Care Sales, 2010-2011 (US$ million)
      • Fig.10: Percentage of Abbott Point of Care Revenue by Region, 2011
    • Accumetrics
      • Recent Key Events
      • Fig.11: Accumetrics Revenue, 2005-2011 (US$ thousand)
      • VerifyNow System
      • Distribution Agreements
    • Akers Biosciences
      • Recent Key Events
      • Current Products
      • Research and Development
      • Current Alliances and Distribution Agreements
      • Financial Performance
      • Akers Biosciences Operating Results, 2007-2011 (US$ thousands)
      • Fig.12: Percentage of Akers' Revenue by Product Type, 2011
    • Alere
      • Recent Key Events
      • POC Cardiology Diagnostic Products
      • Women's Health
      • RALS-Plus POC IT Solution
      • POC Mergers & Acquisitions
      • Current Alliances
      • Financial Performance
      • Alere - Operating Results, 2007-2011 (US$ million)
      • Fig.13: Percentage of Alere's Revenue by Segment, 2011
      • Fig.14: Percentage of Alere's Revenue by Region, 2011
      • Alere Professional Diagnostics Operating Results, 2007-2011 (US$ million)
      • Professional Diagnostics Net Sales & Services Revenue, 2007-2011 (US$ million)
      • Fig.15: Alere Professional Diagnostics Net Sales & Services Revenue by Product, 2011
      • Alere Consumer Diagnostics Operating Results, 2007-2011 (US$ million)
    • Arkray
      • Recent Key Events
      • POC Testing Products
      • Current Alliances
    • bioMérieux
      • bioNexia POC Tests
      • VIDAS Tests
      • Current Alliances
      • Financial Performance
      • bioMérieux - Operating Results, 2007-2011 (EUR million)
      • Fig.16: Percentage of bioMérieux' Revenue by Product Type, 2011
      • Fig.17: Percentage of bioMérieux's Revenue by Region, 2011
      • Horiba Medical
      • Recent Key Events
      • Haematology Analysers
      • ABX Pentra 400 Clinical Chemistry Analyser
      • Pentra C200 Clinical Chemistry Analyser
      • Financial Performance
      • Fig.18: Percentage of Horiba's Revenue by Division, 2011
    • Horiba Medical - Operating Results, 2007-2011 (¥ million)
      • Fig.19: Percentage of Horiba Medical's Revenue by Region, 2011
      • Fig.20: Percentage of Horiba Medical's Revenue by Product Type, 2011
    • Instrumentation Laboratory
      • Recent Key Events
      • POC Critical Care Diagnostics
      • Purchasing Contracts
    • International Technidyne Corporation
      • Products
      • Current Alliances
      • Financial Performance
      • International Technidyne Operating Results, 2004-2009 (US$ million)
      • Fig.21: International Technidyne Revenue, 2000-2010 (US$ million)
    • Nova Biomedical
      • Critical Care Analysers
      • Hand-Held Analysers
    • Quest Diagnostics
      • HemoCue Products
      • Litigation with EKF Diagnostics
      • Financial Performance
      • Quest Diagnostics - Operating Results, 2007-2011 (US$ million)
      • Quest Diagnostics - Sales and Earnings by Category, 2007-2011 (US$ million)
      • Fig.22: Quest Diagnostics - Revenue by Division, 2011
    • Radiometer (Danaher)
      • Recent Key Events
      • AQT90 FLEX Immunoassay Analyser
      • Blood Gas Analysers
      • AQURE POC Management System
      • RADIANCE IT system
      • Current Alliances
      • Financial Performance
      • Fig.23: Radiometer - Revenue by Region, 2010
    • Response Biomedical
      • Recent Key Events
      • RAMP System
      • Current Alliances
      • Financial Performance
      • Response Biomedical - Operating Results, 2007-2011 (C$ thousands)
      • Response Biomedical - Product Sales by Category, 2009-2011 (C$ thousands)
      • Fig.24: Response Biomedical - Product Sales by Category, 2011
      • Response Biomedical - Revenue by Region, 2009-2011 (C$ thousands)
      • Fig.25: Response Biomedical - Revenue by Region, 2011
      • Roche Diagnostics
      • Recent Key Events
      • Cardiac Testing Products
      • cobas Blood Gas Analysers
      • Urinalysis
      • cobas POC IT Solution
      • Current Alliances and Contracts
      • Financial Performance
      • Roche Diagnostics Operating Results, 2010-2011 (SFr million)
      • Fig.26: Roche Diagnostics - Revenue by Product Line, 2011
      • Fig.27: Roche Professional Diagnostics - Revenue by Region, 2011
    • Siemens Healthcare Diagnostics
      • Recent Key Events
      • Blood Gas Analyser Range
      • Urinalysis
      • Cardiology - Stratus CS Analyzer
      • RAPIDComm Data Management and Connectivity Solution
      • Current Alliances and Supply Contracts
      • Financial Performance

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY

Infectious Diseases

Point of Care Diagnostics - Products, Players and Outlook to 2017

EXECUTIVE SUMMARY

  • INTRODUCTION
  • The Role Of POC Testing in Infectious Disease Diagnostics and Surveillance
  • POC Infectious Disease Testing Products
  • Customers of POC Infectious Disease Tests
  • Regulatory and Reimbursement Environment
  • CLIA Waiver
  • CURRENT MARKET DYNAMICS
  • Fig.1: POC Diagnostics in Relation to the IVD Market, 2011
  • Fig.2: Percentage of POC Diagnostics Market by Product, 2011
  • Regional Perspective
  • Fig.3: Professional POC Diagnostics Market by Region, 2011
  • POC Infectious Disease Testing Market
  • Fig.4: POC Infectious Disease Testing Market, 2007-2011 (US$ million)
  • Fig:5: POC Infectious Disease Testing Market by Product Type, 2011 (%)
  • COMPETITIVE LANDSCAPE
  • Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million)
  • POC Infectious Disease Competitors
  • Market Leaders for POC Infectious Disease Testing Products
  • Select Companies' Infectious Disease Testing Sales, 2008-2011 (US$ million)
  • Fig:6: POC Infectious Disease Testing Market Shares by Competitor, 2011 (%)
  • Merger and Acquisition Activity
  • Key POC Infectious Disease Testing Mergers and Acquisitions, 2008-2012
  • GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
  • Clinical Utility and Accuracy
  • Expanded Access to Screening in the US
  • POC Diagnostics as a Disruptive Technology
  • Future Technology: Next-Generation POC Diagnostic Products
  • Detecting Hospital-Acquired Infections
  • Summary: Market Drivers, Restraints and Opportunities
  • MARKET OUTLOOK
  • Fig.7: POC Infectious Disease Testing Market, 2011-2017E (US$ million)
  • Fig.8: POC Infectious Disease Testing Market Growth Rates, 2008-2017E (US$ million)

PRODUCTS AND TECHNOLOGIES

  • POC RESPIRATORY DISEASE DIAGNOSTICS
  • POC Influenza Testing
  • Performance and Use of Rapid Influenza Tests in the US
  • CDC Recommendations
  • CDC: Influenza Prevalence and Test Accuracy
  • POC Influenza Testing Market
  • Future Prospects
  • CLIA-Waived Flu Detection Products
  • Alere's Influenza Tests
  • Alverix/Becton Dickinson's BD Veritor System
  • Quidel's Sofia Analyzer and Sofia Influenza A+B Fluorescent Immunoassays
  • Quidel's QuickVue Influenza Tests
  • SA Scientific's SAS FluAlert
  • Other POC Flu Detection Products
  • bioMérieux' bioNexia Influenza A+B Tests
  • IQuum's Liat Influenza A/B Assay and the Liat Analyzer
  • Jant Pharmacal's Accutest Flu Test
  • Medix Biochemica's Actim Influenza A&B
  • Meridian Bioscience's TRU FLU
  • Mizuho Medy's Quick Chaser Flu A,B
  • OraSure Technologies' OraSure QuickFlu Rapid Flu A+B Test
  • Princeton BioMeditech's BioSign Flu A+B
  • Response Biomedical's Influenza A+B Test
  • Sekisui Diagnostics' OSOM Influenza A & B Test
  • Products in Development
  • Alere's iNAT System
  • Chembio's DPP Influenza Tests
  • Cepheid's GeneXpert
  • Enigma Diagnostics
  • Enigma ML (Mini Laboratory)
  • Lucigen's Nucleic Acid-Based POC Test
  • Respiratory Syncytial Virus Testing
  • Alverix/BD's BD Veritor System
  • Quidel's Sofia RSV Fluorescent Immunoassay
  • Quidel's QuickVue RSV 10
  • Response Biomedical's RSV Test
  • BioFire Diagnostics' FilmArray System
  • FilmArray Respiratory Panel
  • Other Respiratory Tests
  • Ani Biotech's Biocard Chlamydia Pneumoniae IgM Test
  • GenBio's ImmunoFLOW Mycoplasma IgM Test
  • Trinity Biotech's Uni-Gold Tests

OTHER PRIMARY CARE POC TESTS

  • Group A Streptococcus Tests
  • Currently Available POC Tests
  • Quidel's Sofia Strep A Fluorescent Immunoassay
  • H. pylori Tests
  • Currently Available H. pylori Tests
  • Exalenz Bioscience's BreathID System
  • Otsuka America Pharmaceutical's BreathTek UBT
  • Mononucleosis Tests
  • Currently Available POC Tests
  • Rotavirus and Adenoviral Enteritis Tests
  • Ani Biotech's Biocard Tests
  • Meridian Bioscience ImmunoCard STAT! Rotavirus
  • Nicox/Rapid Pathogen Screening's AdenoPlus
  • Orion Diagnostica's Diarlex, Rotalex and Adenolex Tests
  • Other Products
  • Ani Biotech's Biocard Candida and Trichomonas Tests
  • Gryphus Diagnostics' BVBLUE
  • Medix Biochemica's Actim Noro
  • POC HIV TESTING
  • Fig.9: HIV Prevalence, 2001-2011 (millions)
  • Fig.10: HIV Prevalence by Region, 2011
  • Fig.11: Number of New HIV Infections, 2001-2011 (million)
  • Fig.12: New HIV Infections by Region, 2011
  • Efforts to Combat HIV
  • Screening in the US
  • The Role of POC Testing
  • Market Dynamics
  • Fig:13: Global POC HIV Testing Market Shares by Company, 2011
  • Fig:14: US POC HIV Testing Market Shares by Company, 2011
  • Rapid HIV Tests
  • Currently Available POC Tests
  • CLIA-Waived Tests
  • bioLytical Laboratories' INSTI Rapid HIV-1 Antibody Test
  • Chembio Diagnostics' Lateral Flow HIV Tests
  • Fig.15: Chembio: HIV Lateral Flow Test Sales, 2008-2011 (US$ thousands)
  • OraSure Technologies' OraQuick Rapid Test Platform
  • OraSure's POC HIV Testing Sales, 2010-2011 (US$ thousands)
  • Fig.16: OraSure's OraQuick HIV Revenue by Region, 2011
  • Trinity Biotech's POC HIV Tests
  • Non-CLIA-Waived Tests
  • Alere's SD, Determine and Clearview HIV Tests
  • bioMérieux's VIKIA HIV 1/2 HIV Test
  • Bio-Rad's Multispot HIV-1/HIV-2 Rapid Test
  • Calypte Biomedical's Aware HIV-1/2 Tests
  • Fig.17: Calypte Biomedical: Aware Rapid HIV Test Sales, 2009-2011 (US$ thousands)
  • Chembio's Dual Path Platform Technology Products
  • FirstVue HIV Tests
  • Hema Diagnostic Systems
  • IND Diagnostic's One-Step Anti-HIV (1+2) Tests
  • Lab21's Biotec Tests
  • MedMira's Reveal HIV Tests
  • Savyon Diagnostics' HIVSav 1/2/0 Rapid SeroTest
  • Unimed's FirstSign HIV Duo
  • Products in Development
  • Alere's NAT Analyzer
  • Calypte Biomedical's Aware II (The Ani Platform)
  • Cepheid's GeneXpert System and Xpert HIV Viral Load Test
  • Chembio's SURE CHECK HIV OTC
  • IQuum's Liat System
  • MedMira's Dual HIV Test
  • POC CD4 Testing
  • Alere's Pima Point-of-Care CD4 Analyser
  • In Development - Daktari Diagnostics' Daktari CD4

POC HEPATITIS TESTS

  • Hepatitis B
  • Hepatitis C
  • HCV Screening in the US
  • POC HCV Testing
  • POC and Rapid HCV Tests: Sensitivity & Specificity
  • Available POC Tests
  • Key Rapid Tests
  • Alfa Scientific Designs' Instant-View Tests
  • bioMérieux's VIKIA HBs Ag Test
  • FirstVue's Hepatitis Rapid Test Kits
  • OraSure Technologies' OraQuick HCV Rapid Antibody Test
  • OraSure's POC HCV Testing Sales, 2010-2011 (US$ thousands)
  • Fig.18: OraQuick HCV Revenue by Region, 2011
  • Runbio Biotech's One Step Tests
  • In Development
  • bioLytical Laboratories' INSTI Test
  • Chembio Diagnostics' DPP HCV Test
  • MedMira's Rapid Tests

COMBINATION POC TESTS

  • TB and HIV
  • MedMira's Multiplo Rapid Tests
  • Multiplo HIV/HCV
  • Multiplo HBV/HIV/HCV
  • Multiplo TP/HIV
  • Products in Development
  • Chembio Diagnostics' DPP Syphilis/HIV Combination Test
  • MedMira's Development Products

POC TUBERCULOSIS TESTING

  • Multidrug-Resistant TB
  • TB and HIV
  • POC TB Testing
  • Cepheid's Xpert MTB/RIF
  • Concessionary Pricing
  • Alere's Determine TB LAM Ag Test
  • Products In Development
  • Alere/TwistDx's Recombinase Polymerase Amplification Technology
  • Applied Nanodetectors and the London School of Hygiene & Tropical Medicine
  • Chembio's DPP Tuberculosis Test
  • Enigma Diagnostics' Enigma ML (Mini Laboratory)

POC SEXUALLY-TRANSMITTED INFECTION TESTING

  • STI Testing and the Role of POC Diagnostics
  • POC STI Diagnostic Products
  • Currently Available POC Tests
  • Ani Biotech's Biocard Candida and Trichomonas Tests
  • Focus Diagnostics' HerpeSelect Express HSV-2
  • Gryphus Diagnostics' BVBLUE
  • Hema Diagnostic Systems' Rapid 1-2-3 Hema Syphilis
  • MedMira's Reveal TP Rapid Syphilis Test
  • Quidel's QuickView Chlamydia Test
  • RunBio Biotech's Tests
  • Savyon Diagnostics' SavvyCheck
  • Sekisui Diagnostics' OSOM Tests
  • Trinity Biotech's Uni-Gold HSV-2 Rapid Test
  • Products In Development
  • Atlas Genetics' POC System
  • bioLytical Laboratories' INSTI Test
  • Chembio's DPP Syphilis Tests
  • GenBio's ImmunoFLOW Herpes Simplex Virus Test
  • Randox Laboratories' Lab-on-a-Chip

POC TROPICAL DISEASE TESTS

  • Common Tropical Diseases
  • Malaria
  • Dengue Fever
  • Leptospirosis
  • Visceral Leishmaniasis
  • Typhoid
  • POC Testing
  • Currently Available POC Tests
  • Alere's Standard Diagnostics Tests
  • SD BIOLINE HAT
  • Hema Diagnostic Systems' Malaria and Typhoid Tests
  • Lab21's Tropical Disease Tests
  • Quest Diagnostics' Focus Dengue Rapid Tests
  • Products in Development
  • Chembio's DPP Leptospirosis
  • Chembio's DPP Visceral Leishmaniasis

EMERGING TECHNOLOGIES

  • POC Hospital-Acquired Infection Testing
  • Available Products and Developments
  • New-Generation POC Diagnostic Platform Technologies
  • Alere's POC Molecular Diagnostics Technologies
  • Ionian Technologies' Nicking Enzyme Amplification Reaction Technology
  • TwistDx' Recombinase Polymerase Amplification Technology
  • Atlas Genetics' POC System
  • Atonomics' Atolyzer
  • Bio-AMD's MPR and DSR
  • BioFire Diagnostics' FilmArray System
  • FilmArray Blood Culture ID Panel
  • FilmArray GI Panel
  • Biosensia's RapiPlex
  • Cepheid's GeneXpert
  • pes diagnosesysteme' respons IQ
  • Enigma Diagnostics' Products
  • Enigma ML (Mini Laboratory)
  • ResonSense Technology
  • Fiomi Diagnostics (Trinity Biotech) Forecast Technology
  • Immunexpress' SeptiCyte Technology
  • IQuum's Liat System
  • Liat Assays
  • Lucigen's Nucleic Acid-Based POC Tests
  • MycroLab
  • OPKO Health's OPKO Diagnostics Platform
  • Philips' Minicare
  • Radisens Diagnostics' POC Platform
  • Randox Laboratories' Lab-on-a-Chip
  • ReLIA Diagnostic Systems' ReLIA System
  • Rheonix' EncompassMDx Platform
  • T2 Biosystems' T2Dx System
  • Infectious Diseases
  • Tyrian Diagnostics' DiagnostIQ

POC MANUFACTURERS

  • POC COMPANY DIRECTORY

SELECTED COMPANY PROFILES

  • Alere
  • Recent Key Events
  • POC Infectious Disease Tests
  • New Products
  • Standard Diagnostics' Tests
  • Research and Development
  • Infectious Diease Mergers & Acquisitions
  • Ionian Technologies
  • TwistDx
  • Standard Diagnostics
  • Mologic, Jinsung Meditech, Biolinker and Long Chain International Corp
  • ACON Laboratories' Rapid Diagnostics Assets
  • Matria Healthcare
  • BBI Holdings
  • Other Acquisitions
  • Contracts and Alliances
  • OraSure Technologies
  • Chembio
  • Trinity Biotech
  • Financial Performance
  • Alere - Operating Results, 2007-2011 (US$ million)
  • Fig.19: Percentage of Alere's Revenue by Segment, 2011
  • Fig.20: Percentage of Alere's Revenue by Region, 2011
  • Alere Professional Diagnostics: Operating Results, 2007-2011 (US$ million)
  • Alere Professional Diagnostics: Net Sales & Services Revenue, 2007-2011 (US$ million)
  • Fig.21: Alere Professional Diagnostics: Net Sales & Services Revenue by Product, 2011
  • Latest Results
  • Calypte Biomedical
  • Aware Rapid Test Product Line
  • Aware HIV-1/2 OMT (Oral fluid)
  • Aware HIV-1/2 Oral OTC
  • Products in Development - Aware II (The Ani Platform)
  • Current Alliances
  • Manufacturing Contracts
  • Financial Performance
  • Calypte Biomedical: Operating Results, 2007-2011 (US$ thousands)
  • Calypte Biomedical: Revenue by Product Line, 2009-2011 (US$ thousands)
  • Fig.22: Calypte Biomedical: Percentage of Revenue by Product Line, 2011
  • Latest Results
  • Chembio Diagnostics
  • Recent Key Events
  • Lateral Flow Rapid HIV Tests
  • Dual Path Platform Technology Products
  • DPP HIV 1/2 Assay
  • DPP HIV 1/2 Confirmatory Test
  • Other Tests
  • Research and Development
  • SURE CHECK HIV OTC
  • DPP Technology Products in Development
  • Current Alliances and Contracts
  • Battelle Memorial Institute
  • Oswaldo Cruz Foundation of Brazil
  • National Institutes of Health
  • Alere
  • Infectious Disease Research Institute
  • Bio-Rad Laboratories
  • Financial Performance
  • Chembio - Operating Results, 2007-2011 (US$ thousands)
  • Chembio - Revenue by Type, 2008-2011 (US$ thousand)
  • Chembio - Product Sales by Region, 2010-2011 (US$ thousand)
  • Fig.23: Percentage of Chembio's Revenue by Type, 2011
  • Fig.24: Percentage of Chembio's Product Sales by Region, 2011
  • Latest Results
  • MedMira
  • Recent Key Events
  • Rapid Tests
  • Multiplo HIV/HCV
  • Multiplo HBV/HIV/HCV
  • Multiplo TP/HIV
  • Reveal HIV Tests
  • Reveal TP Rapid Syphilis Test
  • Reveal/MedMira hp Test H. pylori Test
  • R&D Activities
  • Dual HIV Test
  • Current Alliances
  • United States Army
  • Advance Aid
  • Triplex International Biosciences
  • VWR International
  • Vitest
  • Financial Performance
  • MedMira - Operating Results, 2008-2012 (C$ thousands)
  • MedMira - Revenue by Region, 2007-2012 (C$ thousands)
  • Fig.25: MedMira - Revenue by Region, 2012
  • Latest Results
  • Meridian Bioscience
  • TRU FLU and TRU RSV
  • ImmunoCard STAT! HpSA H. pylori Test
  • ImmunoCard STAT! Rotavirus
  • ImmunoCard STAT! Strep A
  • ImmunoCard STAT! MONO
  • ImmunoCard STAT! hCG Combo Test
  • Financial Performance
  • Meridian Bioscience - Operating Results, 2008-2012 (US$ million)
  • Meridian Bioscience - Third-Party Sales by Segment, 2008-2012 (US$ million)
  • Meridian Bioscience - Operating Income by Segment, 2008-2012 (US$ million)
  • Fig.26: Meridian Bioscience - Revenue by Segment, 2012
  • Meridian Bioscience - European Diagnostics Sales by Country, 2006-2011 (US$ million)
  • Outlook
  • OraSure Technologies
  • Recent Key Events
  • OraQuick Rapid Test Platform
  • OraSure's OraQuick ADVANCE HIV Test
  • OraSure's OraQuick In-Home HIV Test
  • OraQuick HCV Rapid Antibody Test
  • OraSure QuickFlu Rapid Flu A+B Test
  • Products in Development
  • Current Alliances and Licensing Agreements
  • Princeton BioMeditech
  • Alere
  • Merck
  • Ortho-Clinical Diagnostics
  • Financial Performance
  • OraSure - Operating Results, 2007-2011 (US$ million)
  • Fig.27: OraSure - Revenue by Business Area, 2011
  • OraSure Infectious Disease Testing Sales, 2010-2011 (US$ thousands)
  • Fig.28: OraQuick HIV Revenue by Region, 2011
  • Fig.29: OraQuick HCV Revenue by Region, 2011
  • Latest Results and Outlook
  • Quest Diagnostics
  • Focus Diagnostics' POC Products
  • HerpeSelect Express HSV-2
  • Focus Dengue Rapid Tests
  • Financial Performance
  • Quest Diagnostics - Operating Results, 2007-2011 (US$ million)
  • Quest Diagnostics - Sales and Earnings by Category, 2007-2011 (US$ million)
  • Fig.30: Quest Diagnostics - Revenue by Division, 2011
  • Latest Results and Outlook
  • Quidel
  • Recent Key Events
  • Sofia Analyzer and the Sofia Influenza A+B Fluorescent Immunoassay
  • QuickVue Rapid Tests
  • QuickVue Influenza Tests
  • QuickVue Group A Strep Tests
  • QuickVue RSV Tests
  • QuickVue+ Infectious Mononucleosis
  • QuickVue H. Pylori gII Test
  • Financial Performance
  • Quidel - Operating Results, 2007-2011 (US$ million)
  • Quidel - Revenue by Product Type, 2008-2011 (US$ million)
  • Fig.31: Quidel - Revenue by Product Type, 2011
  • Fig.32: Quidel - Infectious Disease Revenue, 2005-2011 (US$ million)
  • Quidel - Revenue by Region, 2005-2011 (US$ million)
  • Fig.33: Quidel - Revenue by Region, 2011
  • Latest Results and Outlook
  • Sekisui Diagnostics
  • Point of Care Tests
  • OSOM RSV/Adenovirus Rapid Test
  • OSOM Influenza A & B Test
  • OSOM H. pylori
  • OSOM Ultra Strep A
  • OSOM Strep A
  • OSOM Mono
  • OSOM Trichomonas Rapid Test
  • OSOM BVBLUE Test
  • OSOM C. difficile Toxin A/B Test
  • Thermo Fisher Scientific
  • Sure-Vue Tests
  • Remel's Xpect Tests
  • Trinity Biotech
  • POC HIV Tests
  • Uni-Gold Recombigen HIV
  • Other POC Tests
  • Uni-Gold Giardia Test
  • Uni-Gold HSV-2 Rapid
  • Uni-Gold Legionella Urinary Antigen PLUS
  • Fiomi Diagnostics
  • Alere Licence
  • Financial Performance
  • Trinity Biotech Operating Results, 2007-2011 (US$ million)
  • Trinity Biotech - Sales by Product Line, 2006-2011 (US$ million)
  • Fig.34: Trinity Biotech - Sales by Product Type, 2011
  • Latest Results and Outlook

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY

Physician-based

Point-of-Care Diagnostics: - - Products, Players and Outlook to 2017

MARKET OVERVIEW

  • EXECUTIVE SUMMARY
  • INTRODUCTION
    • Physician's Office POC Testing
    • The Role of POC Testing in a Physician's Office
    • Regulatory and Reimbursement Environment
    • CLIA Waiver
  • CURRENT MARKET DYNAMICS
    • Fig.1: POC Diagnostics in Relation to the IVD Market, 2011
    • Fig.2: Percentage of POC Diagnostics Market by Product, 2011
    • Regional Perspective
    • Fig.3: Professional POC Diagnostics Market by Region, 2011
    • Physician's Office POC Testing Market
    • Addressable Markets for Physician's Office POC Testing, 2007-2011 (US$ million).
    • Fig.4: Addressable Markets for Physician's Office POC Testing, 2011
    • Fig.5: Physician's Office POC Testing Market, 2011
  • GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
    • POC Diagnostics and the Economy
    • The Burden of Chronic Disease and Preventative Medicine
    • Clinical Utility and Accuracy
    • POC Diagnostics as a Disruptive Technology
    • Emerging Technologies
    • Summary: Market Drivers, Restraints and Opportunities
  • COMPETITIVE LANDSCAPE
    • Market Leaders for Physician's Office POC Testing Products
    • Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million)
    • Merger and Acquisition Activity
    • Key POC Diagnostics Mergers and Acquisitions, 2008-2011
  • FUTURE MARKET PROSPECTS
    • Addressable Markets for Physician's Office POC Testing, 2011-2017E (US$ million)
    • Growth in the Addressable Markets for Physician's Office POC Testing, 2008-2017E (%)
    • Physician's Office POC Testing Market, 2011-2012E (US$ million)
    • Fig.6: Physician's Office POC Testing Market, 2012(E)
  • PHYSICIAN'S OFFICE POC PRODUCTS AND TECHNOLOGIES
  • POC HBA1C TESTING
    • Diabetes Prevalence and Burden to the Healthcare System
    • Fig.7: Diabetes Prevalence by Geographic Region, 2011-2030
    • Diabetes Prevalence for the Top 10 Countries, 2011-2030 (million)
    • Diabetes Management and the Role of HbA1c Testing
    • POC HbA1c Testing Market
    • Fig.8: Global POC HbA1c Testing Market, 2007-2017E (US$ million)
    • POC HbA1c Products
    • ApexBio's A1C Express
    • Alere/Axis-Shield's Afinion HbA1c and NycoCard HbA1c Tests
    • Bayer's A1CNow Products
    • Bio-Rad's in2it A1C Analyser
    • DiaSys Diagnostic Systems' InnovaStar
    • Ceragem Medisys' HbA1c Analysers
    • EKF Diagnostics' Quo-Lab, Quo-Test and Biosen HbA1c Analysers
    • Infopia's Easy/Clover A1c
    • Siemens' DCA Vantage Analyser
    • Tosoh Bioscience's G8 HPLC Analyzer
    • In Development

POC CHOLESTEROL TESTING

  • Cholesterol Testing and Preventative Medicine
  • POC Cholesterol Testing Market Dynamics
    • Fig.9: Global POC Cholesterol Testing Market, 2007-2017E (US$ million)
    • Fig:10: POC Cholesterol Testing Market by End User, 2011
  • Available Products
    • Alere's Cholestech LDX System
    • Akers Biosciences' Tri-Cholesterol Check
    • Chematics' Chemcard Cholesterol Test
    • General Life Biotechnology's BeneCheck LipidEx ST
    • Infopia's Lipid Pro
    • Jant Pharmacal's LipidPlus Lipid Profile and Glucose Test System
    • Miraculins' PreVu Point of Care Skin Sterol Test
    • Distribution Agreements
    • Polymer Technology Systems' CardioChek PA
    • Roche's Accutrend Plus
    • Syntron Bioresearch's Venture Total Cholesterol Test
    • Products in Development
    • Roche and Panasonic Healthcare

POC COAGULATION TESTING

  • POC Coagulation Testing Market Dynamics
    • Fig.11: Global POC Coagulation Market, 2007-2017E (US$ million)
    • The Impact of New-Generation Anticoagulants
  • Patient Self-Testing and Issues for Doctors
    • CoaguSense's CoaguSense PT/INR Monitoring System
    • Alere's INRatio2 System
    • International Technidyne Corporation's ProTime Microcoagulation System
    • Roche's CoaguChek XS
  • Professional Use Products
    • Alere's Axis-Shield Products
    • Helena Laboratories' Cascade POC System
    • Instrumentation Laboratory's GEM PCL Plus
    • Roche's CoaguChek Systems
    • CoaguChek XS Pro
    • CoaguChek XS Plus
    • CoaguChek XS
    • CoaguChek Link
  • Products in Development
    • Bio-AMD's COAG
    • Siemens/Universal Biosensors' POC Coagulation Tests

POC CLINICAL CHEMISTRY AND HAEMATOLOGY PRODUCTS

  • Multi-Functional POC Clinical Chemistry Analysers
  • Handheld POC Analysers Suitable for Use by Physicians
    • Abaxis' Piccolo xpress
    • Abbott's i-STAT System
    • Alere/Axis-Shield's Afinion POC System
    • Alere/Axis-Shield's NycoCard System
  • Benchtop Systems Suitable for Physician's Laboratories
    • Alfa Wassermann's ACE Clinical Chemistry Systems
    • Arkray's SpotChem Systems
    • SpotChem Test Strips
    • Audit Diagnostics' Liqui-Stat System
    • DiaSys Diagnostic Systems' InnovaStar
    • Horiba's ABX Pentra Clinical Chemistry Analysers
    • Ortho-Clinical Diagnostics' VITROS DT60 II Chemistry System
    • Qualigen's FastPack IP System
    • Samsung's LABGEO Clinical Chemistry Analysers
    • Tosoh Bioscience's AIA Immunoassay Analysers
  • POC Haematology and Haemoglobin Analysers
  • POC Haemoglobin Systems
    • POC Analyser Accuracy
    • ACON Laboratories' Mission Hb Hemoglobin Testing Systems
    • ApexBio's HemoSmart Haemoglobin Screening System
    • Audit Diagnostics' Hb-Stat
    • Ceragem Medisys' CERA-CHEK Hb Plus
    • EKF Diagnostics' Products
    • General Life Biotechnology's BeneCheck Hb Hemoglobin Test System
    • OrSense's Glasswing and NBM 200 Systems
    • Quest Diagnostics' HemoCue Haemoglobin Systems
    • URIT Medical's URIT-12 Hemoglobin Meter

POC C-REACTIVE PROTEIN DIAGNOSTICS

  • Abaxis' MetLyte Plus CRP and BioChemistry Panel Plus
  • Alere/Axis-Shield
  • bioMérieux bioNexia CRP Test
  • LifeAssays' CRP
  • Medix Biochemica's Actim CRP
  • Orion Diagnostica's QuikRead and QuikRead go Systems

POC PHYSICIAN'S OFFICE INFECTIOUS DISEASE TESTS

  • Current Market Dynamics
    • Fig.12: Market for POC Infectious Disease Tests used in a Physician's Office, 2007-2017E (US$ million)
  • POC Influenza Testing
    • Performance and Use of Rapid Influenza Tests in the US
      • CDC Recommendations
    • CDC: Influenza Prevalence and Test Accuracy
    • POC Influenza Testing Market
    • Future Prospects
    • CLIA-Waived Flu Detection Products
      • Alere's Influenza Tests
      • Becton Dickinson's BD Veritor System
      • Quidel's Sofia Analyzer and Sofia Influenza A+B Fluorescent Immunoassays
      • Quidel's QuickVue Influenza Tests
      • SA Scientific's SAS FluAlert
    • Other POC Flu Detection Products
      • bioMérieux' bioNexia Influenza A+B Tests
      • IQuum's Liat Influenza A/B Assay and the Liat Analyzer
      • Jant Pharmacal's Accutest Flu Test
      • Medix Biochemica's Actim Influenza A&B
      • Meridian Bioscience's TRU FLU
      • Mizuho Medy's Quick Chaser Flu A,B
      • OraSure Technologies' OraSure QuickFlu Rapid Flu A+B Test
      • Princeton BioMeditech's BioSign Flu A+B
      • Response Biomedical's Influenza A+B Test
      • Sekisui Diagnostics' OSOM Influenza A & B Test
    • Products in Development
      • Chembio's DPP Influenza Tests
      • Cepheid's GeneXpert
      • Lucigen's Nucleic Acid-Based POC Test
  • Respiratory Syncytial Virus
    • Quidel's Sofia RSV Fluorescent Immunoassay
    • Quidel's QuickVue RSV 10
    • Response Biomedical's RSV Test
  • Other Respiratory Tests
    • Ani Biotech's Biocard Chlamydia Pneumoniae IgM Test
    • GenBio's ImmunoFLOW Mycoplasma IgM Test
  • Group A Streptococcus Tests
    • Currently-Available POC Strep A Tests
    • Quidel's Sofia Strep A Fluorescent Immunoassay
  • H. pylori Tests
    • Currently-Available H. pylori Tests
    • Exalenz Bioscience's BreathID System
    • Otsuka America Pharmaceutical's BreathTek UBT
  • Mononucleosis Tests
    • Currently-Available POC Mono Tests
  • Rotavirus and Adenoviral Enteritis Tests
    • Ani Biotech's Biocard Tests
    • Meridian Bioscience ImmunoCard STAT! Rotavirus
    • Nicox/Rapid Pathogen Screening's AdenoPlus
    • Orion Diagnostica's Diarlex, Rotalex and Adenolex Tests
  • Women's Heath Diagnostics
    • Ani Biotech's Biocard Candida and Trichomonas Tests
    • Gryphus Diagnostics' BVBLUE
    • Quidel's QuickView Chlamydia Test
    • RunBio Biotech's Tests
    • Savyon Diagnostics' SavvyCheck

POC TUMOUR MARKER TESTING

  • Fig.13: Global POC Tumour Markers Market, 2007-2017E (US$ million)
  • Prostate Specific Antigen Tests
    • Available Tests
    • Mediwatch's PSAwatch
    • OPKO Health's OPKO Diagnostics Platform
  • Occult Blood Testing
    • ACON Laboratories' Mission FOB Reagent Strips
    • Aerscher Diagnostics' HemaPrompt
    • Alere's Tests
    • Beckman Coulter's Hemoccult Tests
    • Biomerica's EZ Detect
    • bioMérieux' bioNexia FOBplus
    • Helena Laboratories' ColoCare
    • Immunostics' Hema-Screen
    • Orion Diagnostica's QuikRead System and Orion Q-flow FOB
    • Princeton BioMeditech's BioSign iFOBTest
    • Quest Diagnostics' InSure Quik F I T
    • Quidel's QuickVue iFOB
    • Other Available FOB Tests
    • Gastric Occult Blood Tests
  • CEA Testing
  • Alpha Fetoprotein Testing
  • Bladder Cancer Testing
    • Alere's Matritech NMP22 BladderChek Test
    • bioMérieux' bioNexia BTA
    • Mediwatch's Bladderwatch BTA Test
  • Novel Products in Development
    • Bioscience Ventures/ Serascience's POC Myeloma Test
    • Guided Therapeutics' Non-Invasive Cancer Diagnostic Products
    • LuViva Advanced Cervical Scan
    • Oesophageal and Other Cancer Detection
    • Infopia's Cancer Diagnosing Sensor

POC URINALYSIS TESTING

  • Fig.9: Global POC Urinalysis Market, 2007-2017E (US$ million)
  • Key Urine Analysis Test Strips
  • Product Highlights
    • 77 Elektronika's DocUReader 2 and DocuReader 2 Pro
    • ACON Laboratories' Mission Products
    • Arkray's Products
    • PocketChem UA
    • AUTION ELEVEN
    • DiaScreen 50 Urine Chemistry Analyser and DiaScreen Reagent Strips
    • Roche's Products
    • Urisys 1100 Urine Analyser
    • Chemstrip Criterion II Analyzer
    • Chemstrips/Combur-Test Strips
    • Siemens' Products
    • Clinitek Status+
    • Clinitek Status Connect
    • Multistix10 SG Reagent Strips
    • RAPIDComm Data Management and Connectivity Solution
  • Microalbumin Testing
    • Axis-Shield's Afinion ACR Test
    • Biomerica's Fortel Microalbumin Screening-OTC Test
    • Orion Diagnostica's QuikRead U-ALB
    • Quest Diagnostics' HemoCue Albumin 201 System
    • Sekisui Diagnostics' OSOM ImmunoDip Urinary Albumin Test
    • Siemens' Clinitek Microalbumin Strips

OTHER PRODUCTS

  • Alere Heart Check System for Heart Failure Monitoring
  • Liver Function Testing
    • Exalenz Bioscience's BreathID System
    • BreathID Methacetin Breath Test
    • Infopia's Pioneer POCT Liver Test Sensor
  • Thyroid Tests
    • Jant Pharmacal's Accutest TSH
    • Screening Devices Canada's ThyroChek
  • Ani Biotech's Biocard Coeliac Tests
  • Rapid Pathogen Screening's InflammaDry
  • Products in Development
    • Akers Biosciences' BreathPulmo Health Check and Breath Asthma Check
    • POC Breath Asthma Check

EMERGING TECHNOLOGIES

  • Applied Nanodetectors' Sensor Array Platform
  • Ativa Medical's POC System
  • Bio-AMD's MPR
  • Biosensia's RapiPlex
  • Cepheid's GeneXpert
  • MagnaBioSciences' MICT On-Site System
  • Molecular Vision
  • MycroLab
  • OPKO Health's OPKO Diagnostics Platform
  • pes diagnosesysteme' respons IQ
  • Philips' Minicare
  • Radisens Diagnostics' POC Platform
  • T2 Biosystems' T2Dx System
  • T2Hemostasis Assay
  • Tyrian Diagnostics' DiagnostIQ

MANUFACTURERS

  • COMPANY DIRECTORY
  • SELECTED COMPANY PROFILES
  • Abaxis
    • Piccolo xpress
    • Financial Performance
    • Abaxis Operating Results, 2007-2012 (US$ million)
    • Latest Results
  • Akers Biosciences
    • Recent Key Events
    • Current Products
    • PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays
    • Tri-Cholesterol Check
    • Research and Development
    • BreathPulmo Health Check
    • POC Breath Asthma Check
    • Current Alliances and Distribution Agreements
    • PULSE Health
    • Al Tadawi Medical Equip/PharmaNova Medical Equipment
    • Fisher HealthCare
    • US Government Service Administration Schedule Contract
    • Financial Performance
    • Akers Biosciences Operating Results, 2007-2011 (US$ thousands)
    • Fig.15: Percentage of Akers' Revenue by Product Type, 2011
  • Alere
    • Recent Key Events
    • POC Cardiology Diagnostic Products
    • Alere Heart Check System
    • Cholestech LDX
    • INRatio2 System
    • Axis-Shield POC Products
    • Afinion POC System
    • NycoCard
    • Coagulation Products
    • POC Oncology Products
    • POC Infectious Disease Tests
    • POC Mergers & Acquisitions
    • Axis-Shield
    • Medical Automation Systems'
    • Standard Diagnostics
    • Assets from Unotech Diagnostics
    • Mologic, Jinsung Meditech, Biolinker and Long Chain International Corp
    • Zycare, Medim and Biosyn
    • ACON Laboratories' Rapid Diagnostics Assets
    • Matria Healthcare
    • BBI Holdings
    • Other Acquisitions
  • Agreements
    • EKF Diagnostics
    • Spartan Bioscience
    • Financial Performance
    • Alere - Operating Results, 2007-2011 (US$ million)
    • Fig.16: Percentage of Alere's Revenue by Segment, 2011
    • Fig.17: Percentage of Alere's Revenue by Region, 2011
    • Alere Professional Diagnostics: Operating Results, 2007-2011 (US$ million)
    • Alere Professional Diagnostics: Net Sales & Services Revenue, 2007-2011 (US$ million)
    • Fig.18: Alere Professional Diagnostics: Net Sales & Services Revenue by Product, 2011
    • Latest Results
    • Axis Shield - Financial Performance
    • Fig.19: Axis-Shield Revenue by Business Unit, 2010
    • Fig.20: Axis-Shield Revenue by Region, 2010
    • Axis-Shield - POC Segment Operating Results, 2006-2010 (£ million)
    • Axis-Shield - POC Sales by Product Line, 2006-2010 (£ million)
    • Fig.21: Axis-Shield POC Sales by Product, 2010
    • Fig.22: Axis-Shield Afinion Sales by Region, 2010
  • Arkray
    • Recent Key Events
    • POC Testing Products
    • SpotChem EZ Dry Chemistry Analyser
    • SpotChem D-Concept
    • SpotChem CL SB-1440 Automatic Blood Cell Counter
    • PocketChem BA Blood Ammonia Meters
    • Urinalysis
    • Current Alliances
    • ELITech Group
  • Beckman Coulter (Danaher)
    • POC Products
    • Hemoccult Tests
    • Gastroccult
  • International Technidyne Corporation
    • Products
    • ProTime Coagulation Systems
    • Hemochron Whole Blood Coagulation System
    • Current Alliances
    • Roche
    • Financial Performance
    • International Technidyne Operating Results, 2004-2009 (US$ million)
    • Fig.23: International Technidyne Revenue, 2000-2010 (US$ million)
  • Orion Diagnostica
    • QuikRead 101 System
    • QuikRead go
    • Uricult Dipslide Tests
    • Rotaviral and Adenoviral Enteritis Tests
    • Financial Performance
    • Orion Diagnostica - Operating Results, 2007-2011 (EUR million)
  • Meridian Bioscience
    • TRU FLU and TRU RSV
    • ImmunoCard STAT! HpSA H. pylori Test
    • ImmunoCard STAT! Rotavirus
    • ImmunoCard STAT! Strep A
    • ImmunoCard STAT! MONO
    • ImmunoCard STAT! hCG Combo Test
    • Financial Performance
    • Meridian Bioscience - Operating Results, 2008-2012 (US$ million)
    • Meridian Bioscience - Third-Party Sales by Segment, 2008-2012 (US$ million)
    • Meridian Bioscience - Operating Income by Segment, 2008-2012 (US$ million)
    • Fig.24: Meridian Bioscience - Revenue by Segment, 2012
    • Meridian Bioscience - European Diagnostics Sales by Country, 2006-2011 (US$ million)
    • Outlook
  • Quest Diagnostics
    • HemoCue Products
    • Haemoglobin Systems
    • HemoCue Albumin 201 System
    • HemoCue White Blood Cell Analyzer
    • HemoCue WBC DIFF
    • HemoCue Basic Data Management and Connectivity Software
    • Enterix Products
    • InSure Quik F I T Fecal Immunochemical Test
    • Litigation with EKF Diagnostics
    • Financial Performance
    • Quest Diagnostics - Operating Results, 2007-2011 (US$ million)
    • Quest Diagnostics - Sales and Earnings by Category, 2007-2011 (US$ million)
    • Fig.25: Quest Diagnostics - Revenue by Division, 2011
    • Latest Results and Outlook
  • Quidel
    • Recent Key Events
    • Sofia Analyzer and the Sofia Influenza A+B Fluorescent Immunoassay
    • QuickVue Rapid Tests
    • QuickVue Influenza Tests
    • QuickVue Group A Strep Tests
    • QuickVue RSV Tests
    • QuickVue+ Infectious Mononucleosis
    • QuickVue iFOB
    • QuickVue H. Pylori gII Test
    • Financial Performance
    • Quidel - Operating Results, 2007-2011 (US$ million)
    • Quidel - Revenue by Product Type, 2008-2011 (US$ million)
    • Fig.26: Quidel - Revenue by Product Type, 2011
    • Fig.27: Quidel - Infectious Disease Revenue, 2005-2011 (US$ million)
    • Quidel - Revenue by Region, 2005-2011 (US$ million)
    • Fig.28: Quidel - Revenue by Region, 2011
    • Latest Results
  • Roche Diagnostics
    • Recent Key Events
    • CoaguChek Systems
    • CoaguChek XS Pro
    • CoaguChek XS Plus
    • CoaguChek XS
    • CoaguChek Link
    • Urinalysis
    • Urisys 1100 Urine Analyser
    • Chemstrip Criterion II Analyzer
    • Chemstrips/Combur-Test Strips
    • Current Alliances and Contracts
    • Panasonic Healthcare
    • Voluntis
    • Financial Performance
    • Roche Diagnostics Operating Results, 2010-2011 (SFr million)
    • Fig.29: Roche Diagnostics - Revenue by Product Line, 2011
    • Fig.30: Roche Professional Diagnostics - Revenue by Region, 2011
    • Latest Results
  • Sekisui Diagnostics
    • Point of Care Tests
    • OSOM RSV/Adenovirus Rapid Test
    • OSOM Influenza A & B Test
    • OSOM H. pylori
    • OSOM Ultra Strep A
    • OSOM Strep A
    • OSOM Mono
    • OSOM Trichomonas Rapid Test
    • OSOM BVBLUE Test
    • OSOM ImmunoDip Urinary Albumin Test
    • OSOM Pregnancy Tests
  • Siemens Healthcare
    • Products
    • Diabetes Testing - DCA Vantage Analyser
    • Urinlysis Products
    • RAPIDComm Data Management and Connectivity Solution
    • Current Alliances and Supply Contracts
    • Universal Biosensors
    • Premier
    • Roche
    • Financial Performance
    • Latest Results
  • Thermo Fisher Scientific
    • Sure-Vue Tests
    • Remel's Xpect Tests

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY
    • Sources
    • Market forecasts

Point-of-Care Diagnostics

Market Overview

EXECUTIVE SUMMARY

BACKGROUND

  • The Role of POC Testing

CURRENT MARKET DYNAMICS

  • Customers of POC Diagnostic Products
  • Regional Perspective
  • Regulatory and Reimbursement Environment
  • CLIA Waiver

COMPETITIVE LANDSCAPE

  • Industry Consolidation

GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES

  • Clinical Utility and Accuracy
  • POC Diagnostics as a Disruptive Technology
  • Connectivity
  • POC Diagnostics and the Economy
  • Future Technology: Next-Generation POC Diagnostic Products
    • Companion Diagnostics
    • PCR and DNA-Based Technologies
      • Detecting Hospital-Acquired Infections
  • Lab-on-a-Chip Devices and Microfluidics

MARKET OUTLOOK

Back to Top